Biotron announces its lead clinical asset, BIT225 effective against SARS-CoV-2 in animal and cell-based studies

Press/Media

Period27 Nov 2021

Media coverage

1

Media coverage

  • TitleBiotron announces its lead clinical asset, BIT225 effective against SARS-CoV-2 in animal and cell-based studies
    Media name/outletPharmaBiz
    Country/TerritoryIndia
    Date27/11/21
    PersonsJohn Phair
View all 1
View less